AzTrials
AzTrials

Osteo Arthritis KneeNCT06562374

Low Frequency Ultrasound for Osteoarthritis Healing and Rehabilitation

A study testing Low Frequency Ultrasound Therapy in people with Osteo Arthritis Knee and Age Related Osteoporosis, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the safety and effectiveness (how well it works) of a new experimental ultrasound bath device that uses low frequency ultrasound (LFU) that may or may not help healing. Read more about this study

Who is it for?
Ages 40 years and older
What is being tested?
Low Frequency Ultrasound Therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
31 Jul 2024to Feb 2027
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subject has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
  • Adults at least ≥40 years of age at the time of consent.
  • Chronic knee pain within the past 6 months.

Who cannot join

  • Any other arthritic condition clinically classified under ACR guidelines as different from an Osteoarthritic disorder.
  • Any medical condition that, in the opinion of the investigator, would place the subject at increased risk for participation.
  • History of replacement surgery, acupuncture therapy on the joint/knee under study within the past 6 months, or systemic corticosteroids within the study period and previous 30 days.
  • Subject's vitals are unstable or not in range for a safe study visit.
  • History of fecal incontinence.
  • Vomiting/Diarrheal illness within the past 7 days or at any time during the study.
Show all 14Show fewer
  • Any clinically significant rash or formation of rashes or open sores, boils or infected wounds two weeks prior to or during the study.
  • Laboratory evidence of infection or colonization with multidrug resistant pathogens in the past 90 days (eg. vancomycin resistant enterococcus, methicillin-resistant Staphylococcus, Candida auris, extended- spectrum beta lactamase bacteria)
  • History of prior non-compliance or the presence or history of psychiatric conditions (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
  • Females who are pregnant or lactating.
  • Inability to comply with study protocol.
  • Incarcerated individuals.
  • Non-English speaking subjects.
  • Participant's weight must be </= 350 lbs.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas Medical Branch, Galveston

    Galveston, Texas, 777555

Other trials in United States

About this study

The purpose of this study is to determine the safety and effectiveness (how well it works) of a new experimental ultrasound bath device that uses low frequency ultrasound (LFU) that may or may not help healing.

Read the detailed description

This initial study is a pilot study which is going to test the safety and efficacy of the developed ultrasound intervention for osteoarthritis, initially on osteoarthritis of the knee. This study is a pilot study to evaluate two distinct variables. The first is the safety and efficacy of the device, and the second is the potential impact the device may have on patients as their osteoarthritic joints react to the LFU, using patient-reported outcomes associated with this study. The ultrasound will be delivered at a frequency of 33 kHz at power levels of 4-10 Pascals with a program of 1.6 seconds on and 1.6 seconds off. The generators will be encased in epoxy within the Osteoarthritis baths. The intervention will be repeated on every second or third day to allow time for healing

Being tested
Low Frequency Ultrasound Therapy
Keywords
Pain, Osteo Arthritis Knee, Knee, Ultrasound, Joint mobility
Medical subject headings
Osteoporosis, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low Frequency Ultrasound TherapyDevice

    The ultrasound will be delivered at a frequency of 33 kHz at power levels of 4-10 Pascals with a program of 1.6 seconds on and 1.6 seconds off. The generators will be encased in epoxy within the Osteoarthritis baths. The intervention will be repeated on every second or third day to allow time for healing

Study groups in NCT06562374
Study groupRoleWhat they receive
Low Frequency Ultrasound (LFU) InterventionExperimentalSubjects will be given ultrasound at a frequency of 33 kHz with a program of 1.6 seconds on and 1.6 seconds off for 30 min at either a power level of 4 or 10 Pascals to determine which power level is optimal for osteoarthritis. Follow up visits after two-three days will be used to continue therapy.
Receives: Device: Low Frequency Ultrasound Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant-Reported Safety and Efficacy Following Use of Investigational Device

    The number of participants who report any device-related safety concerns following use of the investigational non-significant risk device, as assessed by participant-reported surveys.

    Measured: From device use through completion of the final study visit, up to one year

Secondary outcomes (1)
  1. Participants with Osteoarthritic Joints Reaction to the LFU

    To determine the potential impact the device may have on patients as their osteoarthritic joints react to the LFU, which will be denoted by surveys.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2024
  2. Study start31 Jul 2024
  3. Primary completionFeb 2027 (estimated)
  4. Study completionFeb 2027 (estimated)

Why it stopped: Suspended by IRB

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06562374
Sponsor's protocol ID
23-0164
Status last verified
Mar 2026
First submitted
31 Jul 2024
Last updated
6 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Low Frequency Ultrasound Therapy in people with Osteo Arthritis Knee and Age Related Osteoporosis, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 6 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant-Reported Safety and Efficacy Following Use of Investigational Device (time frame: From device use through completion of the final study visit, up to one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in